Gram-Negative Multidrug-Resistant Pathogens and Their Treatment, 2nd Edition
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: 31 December 2025 | Viewed by 42
Special Issue Editor
2. Department of Biomedicine and Biotechnology, Universidad de Alcalá, 28801 Alcalá de Henares, Spain
Interests: antimicrobial properties; biofilm; carbapenemase-producing Enterobacteriaceae; multidrug-resistant Pseudomonas aeruginosa; extensively drug-resistant pseudomonas aeruginosa; Gram-Negative Bacteria; antibiotic multidrug resistance; antibacterial potential; biofilm inhibition; methicillin-resistant staphylococcus aureus
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The first edition of the Special Issue “Gram-Negative Multidrug Resistant Pathogen and Its Treatment” was closed in 2023:
https://www.mdpi.com/journal/antibiotics/special_issues/BGYK2DT77U
It focuses on a critical and widely faced problem of multidrug resistance and has encouraged us to open a second edition with the same topic. As a continuation of the first Special Issue, this second edition continues to explore the development new antibiotics combating carbapenemase-producing Enterobacteriaceae (CPE), multidrug-resistant (MDR), and extensively drug-resistant (XDR) strains of Pseudomonas aeruginosa. We welcome research articles and reviews on topics including antibiotic resistance epidemiology, particularly in rural areas of low-income countries with limited resources, antimicrobial therapy, clinical strategies, and new antimicrobial agent discovery.
New Focus Areas:
Epidemiological studies on the spread of antimicrobial resistance in low-resource settings, including rural areas where surveillance data are often scarce.
Socioeconomic factors influencing antibiotic misuse and resistance, such as poverty, lack of healthcare access, and unregulated antibiotic use.
A One Health approach to understanding the interplay between human, animal, and environmental health in the context of antimicrobial resistance.
Clinical strategies for managing infections caused by MDR and XDR pathogens, including antimicrobial stewardship programs and infection control measures.
Dr. Ramón Pérez-Tanoira
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- carbapenemase-producing enterobacteriaceae
- multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa
- gram-negative bacteria and antibiotic resistance mechanisms
- multidrug resistant
- extended-spectrum beta-lactamase (ESBL) producers
- antibacterial potential of novel compounds
- biofilm inhibition strategies
- quorum sensing disruption as a therapeutic approach
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
